Region of interest (ROI) analysis of luminescence in the flank tumors on day 8 revealed all groups of CAR and mock T cells preferentially localized to the HT1080-IL13Rα2 tumor, with no significant change in this preference regardless of CAR variant (Fig. 6B). Here, IL13RA2 is linked to neoplasm.